Advanced Materials Technologies,
Journal Year:
2022,
Volume and Issue:
7(11)
Published: May 13, 2022
Cardiovascular
diseases
(CVDs)
are
known
as
the
major
cause
of
death
worldwide.
In
spite
tremendous
advancements
in
medical
therapy,
gold
standard
for
CVD
treatment
is
still
transplantation.
Tissue
engineering,
on
other
hand,
has
emerged
a
pioneering
field
study
with
promising
results
tissue
regeneration
using
cells,
biological
cues,
and
scaffolds.
Three-dimensional
(3D)
bioprinting
rapidly
growing
technique
engineering
because
its
ability
to
create
complex
scaffold
structures,
encapsulate
perform
these
tasks
precision.
More
recently,
3D
made
debut
cardiac
scientists
investigating
this
development
new
strategies
regeneration.
review,
fundamentals
biology,
available
techniques
bioinks,
cells
implemented
briefly
summarized
presented.
Afterwards,
state-of-the-art
works
that
have
utilized
thoroughly
reviewed.
Finally,
regulatory
pathways
their
contemporary
limitations
challenges
clinical
translation
discussed.
Phycology,
Journal Year:
2024,
Volume and Issue:
4(2), P. 276 - 313
Published: May 27, 2024
The
term
‘cosmeceutical’
refers
to
cosmetic
products
that
offer
medicinal
or
drug-like
benefits.
Marine
algae
are
rich
sources
of
bioactive
compounds,
particularly
carbohydrates
and
peptides,
which
have
gained
attention
for
their
potential
in
cosmeceuticals.
These
compounds
abundant,
safe,
minimal
cytotoxicity
effects.
They
various
benefits
the
skin,
including
addressing
rashes,
pigmentation,
aging,
cancer.
Additionally,
they
exhibit
properties
such
as
antimicrobial,
skin-whitening,
anti-aging,
antioxidant,
anti-melanogenic
This
review
surveys
literature
on
cosmeceutical
potentials
algae-derived
focusing
roles
skin
whitening,
anticancer,
anti-inflammatory,
antimicrobial
applications.
discussion
also
includes
current
challenges
future
opportunities
using
purposes.
Advanced Materials Technologies,
Journal Year:
2022,
Volume and Issue:
7(11)
Published: May 13, 2022
Cardiovascular
diseases
(CVDs)
are
known
as
the
major
cause
of
death
worldwide.
In
spite
tremendous
advancements
in
medical
therapy,
gold
standard
for
CVD
treatment
is
still
transplantation.
Tissue
engineering,
on
other
hand,
has
emerged
a
pioneering
field
study
with
promising
results
tissue
regeneration
using
cells,
biological
cues,
and
scaffolds.
Three-dimensional
(3D)
bioprinting
rapidly
growing
technique
engineering
because
its
ability
to
create
complex
scaffold
structures,
encapsulate
perform
these
tasks
precision.
More
recently,
3D
made
debut
cardiac
scientists
investigating
this
development
new
strategies
regeneration.
review,
fundamentals
biology,
available
techniques
bioinks,
cells
implemented
briefly
summarized
presented.
Afterwards,
state-of-the-art
works
that
have
utilized
thoroughly
reviewed.
Finally,
regulatory
pathways
their
contemporary
limitations
challenges
clinical
translation
discussed.
